Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 28, 2007Biology of Blood and Marrow TransplantationOpen Access

Higher Infused Lymphocyte Dose Predicts Higher Lymphocyte Recovery, Which in Turn, Predicts Superior Overall Survival following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

DHDevendra HiwaseRoyal Adelaide HospitalSHSmita HiwaseMBMichael BaileyBrigham Young University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hiwase et al. (2007) studied this question.

synapsesocial.com/papers/6aac883b0facf3ac29f0fbe3https://doi.org/10.1016/j.bbmt.2007.08.051
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model for control of minimal residual disease in malignant hematologic disorders1991 · 60 citations
  2. 2The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma2005 · 25 citations
  3. 3Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma2001 · 269 citations
  4. 4Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose2002 · 187 citations